Ulipristal Acetate for Emergency Contraception

被引:15
|
作者
Snow, Sara E. [1 ]
Melillo, Stephanie N. [1 ]
Jarvis, Courtney I. [2 ]
机构
[1] Biogen Idec Massachusetts Coll Pharm & Hlth Sci, Sch Pharm, Worcester, MA USA
[2] Massachusetts Coll Pharm & Hlth Sci, Sch Pharm, Worcester, MA USA
关键词
CDB-2914; ella; emergency contraception; ulipristal acetate; PROGESTERONE-RECEPTOR MODULATORS;
D O I
10.1345/aph.1P704
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To review the pharmacology, pharmacokinetics, efficacy, and safety of data of ulipristal acetate, a new emergency contraceptive approved for use up to 120 hours after unprotected intercourse. DATA SOURCES: Articles pertaining to the topic were identified and reviewed through searches of PubMed (1994-March 2011) and clinicaltrials.gov, using the key terms ulipristal and CDB-2914. Ella approval documents were obtained and reviewed from Drugs@FDA on the Food and Drug Administration (FDA) Web site. STUDY SELECTION AND DATA EXTRACTION: All published data and FDA approval documents examining pharmacologic, pharmacokinetic, and clinical studies related to ulipristal acetate as an emergency contraceptive were evaluated. Selected studies included 3 randomized trials and 1 meta-analysis. DATA SYNTHESIS: Ulipristal acetate is a progesterone agonist/antagonist emergency contraceptive approved for the prevention of pregnancy to be taken as soon as possible, within 120 hours after unprotected intercourse or a known or suspected contraceptive failure. Based upon results of the Phase 3 clinical trials used to obtain approval, ulipristal acetate administration was at least as effective as levonorgestrel in the reduction of pregnancy rate when studied alone after unprotected intercourse and when taken up to 120 hours after unprotected intercourse. Commonly reported adverse effects associated with ulipristal acetate in trials included headache, breast tenderness, nausea, and abdominal pain. CONCLUSIONS: Ulipristal acetate is effective as an emergency contraceptive for up to 120 hours after unprotected intercourse. Because ulipristal is available only via prescription, it may be covered by insurance. However, the additional factors of travel expenses and time to make and attend a physician appointment must be taken into account when considering use of ulipristal as an emergency contraceptive. Due to the similarity of its structure to mifepristone, controversy regarding ulipristal's mechanism of action has arisen.
引用
收藏
页码:780 / 786
页数:7
相关论文
共 50 条
  • [1] ULIPRISTAL ACETATE FOR EMERGENCY CONTRACEPTION
    Russo, J. A.
    Creinin, M. D.
    [J]. DRUGS OF TODAY, 2010, 46 (09) : 655 - 660
  • [2] Ulipristal acetate for emergency contraception?
    Page, Geert Herman
    Verhaeghe, Veerle
    [J]. LANCET, 2010, 375 (9726): : 1608 - 1608
  • [3] Ulipristal acetate emergency contraception
    Davies, Graham
    [J]. JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2013, 39 (01): : 61 - 61
  • [4] Emergency contraception: potential role of ulipristal acetate
    Gemzell-Danielsson, Kristina
    Meng, Chun-Xia
    [J]. INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2010, 2 : 53 - 61
  • [5] Ulipristal acetate in emergency contraception: mechanism of action
    Mozzanega, Bruno
    Cosmi, Erich
    Nardelli, Giovanni Battista
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2013, 34 (04) : 195 - 196
  • [6] Emergency Contraception Options: Focus on Ulipristal Acetate
    Cameron, Sharon T.
    [J]. CLINICAL MEDICINE INSIGHTS-WOMENS HEALTH, 2012, 5 : 23 - 29
  • [7] Ulipristal acetate: A guide to its use in emergency contraception
    Scott L.J.
    McKeage K.
    Croxtall J.D.
    [J]. Drugs & Therapy Perspectives, 2012, 28 (2) : 6 - 9
  • [8] Ulipristal Acetate A Review of Its Use in Emergency Contraception
    McKeage, Kate
    Croxtall, Jamie D.
    [J]. DRUGS, 2011, 71 (07) : 935 - 945
  • [9] Ulipristal acetate, a progesterone receptor modulator for emergency contraception
    Jadav, Shilpa P.
    Parmar, Dinesh M.
    [J]. JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2012, 3 (02) : 109 - 111
  • [10] Ulipristal acetate and its role in emergency contraception: a comment
    Peitsidis, Panagiotis
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (13) : 1821 - 1823